Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 7 | 2021 | 881 | 1.750 |
Why?
|
| Kidney Transplantation | 10 | 2021 | 647 | 1.700 |
Why?
|
| Renal Dialysis | 8 | 2015 | 856 | 1.270 |
Why?
|
| Catheters, Indwelling | 4 | 2012 | 154 | 0.860 |
Why?
|
| Waiting Lists | 1 | 2021 | 228 | 0.630 |
Why?
|
| Health Policy | 1 | 2021 | 214 | 0.610 |
Why?
|
| Perioperative Care | 1 | 2021 | 195 | 0.610 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 224 | 0.580 |
Why?
|
| Graft Survival | 2 | 2018 | 538 | 0.570 |
Why?
|
| Bacteremia | 3 | 2012 | 407 | 0.550 |
Why?
|
| Biofilms | 3 | 2012 | 88 | 0.530 |
Why?
|
| Cause of Death | 1 | 2018 | 477 | 0.520 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 638 | 0.470 |
Why?
|
| Kidney | 2 | 2015 | 1369 | 0.440 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 188 | 0.430 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 507 | 0.420 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 102 | 0.400 |
Why?
|
| Equipment Contamination | 3 | 2007 | 37 | 0.400 |
Why?
|
| Brain Edema | 1 | 2013 | 68 | 0.400 |
Why?
|
| Medicare | 1 | 2015 | 428 | 0.380 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 148 | 0.370 |
Why?
|
| Catheterization | 3 | 2008 | 235 | 0.370 |
Why?
|
| Aneurysm, False | 1 | 2013 | 103 | 0.370 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2015 | 670 | 0.370 |
Why?
|
| Diabetic Nephropathies | 2 | 2018 | 109 | 0.360 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 129 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 4 | 2012 | 2434 | 0.350 |
Why?
|
| Prosthesis-Related Infections | 1 | 2012 | 179 | 0.340 |
Why?
|
| Bacterial Infections | 1 | 2012 | 308 | 0.330 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 735 | 0.320 |
Why?
|
| Contrast Media | 1 | 2013 | 480 | 0.320 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2007 | 133 | 0.310 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 1972 | 0.250 |
Why?
|
| Middle Aged | 18 | 2018 | 27000 | 0.250 |
Why?
|
| Pyelonephritis | 1 | 2006 | 27 | 0.250 |
Why?
|
| Hip Fractures | 2 | 2017 | 67 | 0.250 |
Why?
|
| Ceftriaxone | 1 | 2006 | 67 | 0.250 |
Why?
|
| Pancreas Transplantation | 2 | 2005 | 38 | 0.250 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2005 | 9 | 0.240 |
Why?
|
| Emphysema | 1 | 2006 | 67 | 0.240 |
Why?
|
| Lipectomy | 1 | 2005 | 8 | 0.240 |
Why?
|
| Nephrotic Syndrome | 1 | 2005 | 48 | 0.230 |
Why?
|
| Proteinuria | 1 | 2005 | 102 | 0.230 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 134 | 0.230 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 65 | 0.230 |
Why?
|
| Castleman Disease | 1 | 2004 | 14 | 0.230 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2004 | 11 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2007 | 372 | 0.220 |
Why?
|
| HIV Seropositivity | 1 | 2004 | 122 | 0.210 |
Why?
|
| Male | 21 | 2021 | 61776 | 0.210 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 161 | 0.210 |
Why?
|
| Preoperative Care | 1 | 2005 | 355 | 0.200 |
Why?
|
| Cryptococcus neoformans | 1 | 2002 | 21 | 0.190 |
Why?
|
| Cryptococcosis | 1 | 2002 | 42 | 0.190 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 450 | 0.180 |
Why?
|
| Humans | 26 | 2021 | 125667 | 0.180 |
Why?
|
| Pleural Effusion | 1 | 2002 | 102 | 0.180 |
Why?
|
| Health Care Rationing | 1 | 2021 | 58 | 0.170 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 142 | 0.170 |
Why?
|
| Adult | 12 | 2018 | 29734 | 0.170 |
Why?
|
| Europe | 1 | 2021 | 357 | 0.170 |
Why?
|
| United States | 6 | 2021 | 10942 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 724 | 0.160 |
Why?
|
| Mass Screening | 1 | 2005 | 787 | 0.160 |
Why?
|
| Organ Transplantation | 1 | 2021 | 168 | 0.160 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 814 | 0.150 |
Why?
|
| Aged | 7 | 2018 | 19900 | 0.150 |
Why?
|
| Intensive Care Units | 1 | 2021 | 493 | 0.140 |
Why?
|
| Abatacept | 1 | 2017 | 21 | 0.140 |
Why?
|
| Minocycline | 2 | 2008 | 38 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 651 | 0.140 |
Why?
|
| Antilymphocyte Serum | 1 | 2017 | 56 | 0.140 |
Why?
|
| Hepatitis C | 1 | 2021 | 367 | 0.140 |
Why?
|
| Acetylcysteine | 2 | 2008 | 72 | 0.140 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 342 | 0.140 |
Why?
|
| Veterans Health | 1 | 2018 | 176 | 0.140 |
Why?
|
| Female | 15 | 2021 | 66998 | 0.130 |
Why?
|
| Transplant Recipients | 1 | 2018 | 219 | 0.130 |
Why?
|
| Ileostomy | 1 | 2016 | 31 | 0.130 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 608 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6607 | 0.120 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 259 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2018 | 4843 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2016 | 277 | 0.110 |
Why?
|
| Pandemics | 1 | 2021 | 1114 | 0.100 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2013 | 8 | 0.100 |
Why?
|
| Hygiene | 1 | 2012 | 27 | 0.100 |
Why?
|
| Hospitals, Veterans | 2 | 2021 | 359 | 0.100 |
Why?
|
| Registries | 1 | 2018 | 1436 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 143 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 578 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 875 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 223 | 0.090 |
Why?
|
| Staphylococcus epidermidis | 2 | 2007 | 39 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 734 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5195 | 0.080 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2008 | 76 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1175 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 6351 | 0.070 |
Why?
|
| Young Adult | 2 | 2018 | 9093 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2017 | 16417 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1901 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 25 | 0.070 |
Why?
|
| Comorbidity | 2 | 2017 | 1537 | 0.070 |
Why?
|
| Gram-Positive Bacteria | 1 | 2007 | 47 | 0.070 |
Why?
|
| Gram-Negative Bacteria | 1 | 2007 | 68 | 0.070 |
Why?
|
| Pyelitis | 1 | 2006 | 2 | 0.070 |
Why?
|
| Staphylococcus aureus | 2 | 2007 | 462 | 0.070 |
Why?
|
| Urinary Calculi | 1 | 2006 | 18 | 0.070 |
Why?
|
| Michigan | 1 | 2006 | 42 | 0.060 |
Why?
|
| Enterococcus | 1 | 2006 | 29 | 0.060 |
Why?
|
| Plasma Cells | 1 | 2006 | 55 | 0.060 |
Why?
|
| Embolism | 1 | 2006 | 47 | 0.060 |
Why?
|
| Granuloma | 1 | 2006 | 68 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2006 | 145 | 0.060 |
Why?
|
| HIV Infections | 1 | 2017 | 1899 | 0.060 |
Why?
|
| Risk Factors | 4 | 2017 | 10340 | 0.060 |
Why?
|
| Remission Induction | 1 | 2006 | 300 | 0.060 |
Why?
|
| Ureteral Obstruction | 1 | 2006 | 105 | 0.060 |
Why?
|
| Pancreatic Diseases | 1 | 2005 | 38 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2109 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3080 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 129 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2016 | 12420 | 0.060 |
Why?
|
| Outpatients | 1 | 2006 | 257 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2006 | 251 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2006 | 1201 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 230 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2012 | 6171 | 0.060 |
Why?
|
| Escherichia coli Infections | 1 | 2006 | 189 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 19441 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2005 | 203 | 0.050 |
Why?
|
| Creatinine | 1 | 2005 | 391 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2006 | 590 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2006 | 1520 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1420 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1816 | 0.050 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 78 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2006 | 435 | 0.050 |
Why?
|
| Length of Stay | 1 | 2007 | 1313 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2002 | 147 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 562 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2005 | 634 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1706 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2006 | 1026 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2005 | 480 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 191 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2021 | 246 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2005 | 1568 | 0.040 |
Why?
|
| Prevalence | 1 | 2005 | 2467 | 0.040 |
Why?
|
| Texas | 1 | 2007 | 3588 | 0.040 |
Why?
|
| Health Facilities | 1 | 2018 | 61 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 494 | 0.040 |
Why?
|
| Causality | 1 | 2017 | 84 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 817 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 51 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 2918 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 378 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 767 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 222 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 3470 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1271 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 321 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1261 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 385 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 616 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1445 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1365 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 1186 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3312 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 3155 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 87 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 267 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 131 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 667 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 1397 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 365 | 0.010 |
Why?
|
| Bacteria | 1 | 2007 | 484 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 317 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 781 | 0.010 |
Why?
|